Novel Strategies in the Study of the Human Gut Microbiota 2.0

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Gut Microbiota".

Deadline for manuscript submissions: 15 July 2024 | Viewed by 587

Special Issue Editor


E-Mail Website
Guest Editor
Dipartimento di Biologia, UNIPI, Università di Pisa, 56127 Pisa, Italy
Interests: bacillus subtilis; bacillus cereus; microbiology; food microbiology and safety

Special Issue Information

Dear Colleagues,

The homeostasis of the human gastrointestinal tract is strictly dependent on the resident gut microbiota, a complex and plastic community of thousands of microbial species that live permanently or more or less temporarily in the intestinal lumen or in association with the intestinal mucosa. The study of the composition and fluctuation of the intestinal microbiota in healthy humans and in particular diseases may be of great help for the comprehension of the roles that microbes play in sustaining host health as well as of the interactions between microbes and human cells. From this perspective, such studies might take advantage of animal models or in vitro systems aimed at mimicking the intestinal environment.

The aim of this Special Issue is to provide a collection of articles on microbiota composition and its effect on human health, particularly focusing on strategies that can be adopted to study this complex and plastic microbial community, in vivo or in vitro.

As the Guest Editor of this Special Issue, I invite you to submit research articles, review articles, and short communications related to “Novel Strategies in the Study of the Human Gut Microbiota”.

Dr. Francesco Celandroni
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gut microbiota
  • homeostasis
  • probiotics
  • prebiotics
  • animal models
  • in vitro models

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 2316 KiB  
Article
Innovative Biomarkers for Obesity and Type 1 Diabetes Based on Bifidobacterium and Metabolomic Profiling
by Angelica Nobili, Marco Pane, Mariya Skvortsova, Meryam Ben Salem, Stephan Morgenthaler, Emily Jamieson, Marina Di Stefano, Eirini Bathrellou, Eirini Mamalaki, Victoria Ramos-Garcia, Julia Kuligowski, Miltiadis Vasileiadis, Panagiotis Georgiadis, Marika Falcone and Paulo Refinetti
Microorganisms 2024, 12(5), 931; https://doi.org/10.3390/microorganisms12050931 - 3 May 2024
Viewed by 443
Abstract
The role of Bifidobacterium species and microbial metabolites such as short-chain fatty acids (SCFAs) and human milk oligosaccharides in controlling intestinal inflammation and the pathogenesis of obesity and type 1 diabetes (T1D) has been largely studied in recent years. This paper discusses the [...] Read more.
The role of Bifidobacterium species and microbial metabolites such as short-chain fatty acids (SCFAs) and human milk oligosaccharides in controlling intestinal inflammation and the pathogenesis of obesity and type 1 diabetes (T1D) has been largely studied in recent years. This paper discusses the discovery of signature biomarkers for obesity and T1D based on data from a novel test for profiling several Bifidobacterium species, combined with metabolomic analysis. Through the NUTRISHIELD clinical study, a total of 98 children were recruited: 40 healthy controls, 40 type 1 diabetics, and 18 obese children. Bifidobacterium profiles were assessed in stool samples through an innovative test allowing high taxonomic resolution and precise quantification, while SCFAs and branched amino acids were measured in urine samples through gas chromatography–mass spectrometry (GC-MS). KIDMED questionnaires were used to evaluate the children’s dietary habits and correlate them with the Bifidobacterium and metabolomic profiles. We found that B. longum subs. infantis and B. breve were higher in individuals with obesity, while B. bifidum and B. longum subs. longum were lower compared to healthy individuals. In individuals with T1D, alterations were found at the metabolic level, with an overall increase in the level of the most measured metabolites. The high taxonomic resolution of the Bifidobacterium test used meant strong correlations between the concentrations of valine and isoleucine, and the relative abundance of some Bifidobacterium species such as B. longum subs. infantis, B. breve, and B. bifidum could be observed. Full article
(This article belongs to the Special Issue Novel Strategies in the Study of the Human Gut Microbiota 2.0)
Back to TopTop